论文部分内容阅读
目的探讨依达拉奉联合疏血通治疗老年脑梗死患者的效果。方法选取2013年2月—2016年2月收治的136例老年脑梗死患者,将患者随机分到对照组和观察组各68例,对照组采取依达拉奉单用治疗,观察组采取依达拉奉与疏血通联合治疗,比较两组患者的椎基底动脉血流速度变化情况、神经功能缺损功能变化情况以及两组患者的临床疗效。结果治疗后,两组患者的基底动脉(BA)、左椎动脉(LVA)、右椎动脉(RVA)均明显高于治疗前(均P<0.05);且观察组显著高于对照组(均P<0.05)。治疗后,两组患者的神经功能缺损情况及日常生活能力均优于治疗前(均P<0.05);且观察组显著优于对照组(均P<0.05)。观察组的总有效率为97.06%,明显高于对照组的89.71%,差异有统计学意义(P<0.05)。结论在老年脑梗死患者中应用依达拉奉与疏血通联合治疗,能有效改善患者的椎基底动脉血流情况,并有效改善患者的神经功能缺损情况,提高临床治疗疗效。
Objective To investigate the effect of edaravone combined with Shuxuetong in the treatment of elderly patients with cerebral infarction. Methods A total of 136 elderly patients with cerebral infarction who were admitted to our hospital from February 2013 to February 2016 were randomly divided into control group and observation group (n = 68). The control group was treated with edaravone alone and the control group Lavong and Shuxuetong combination therapy, vertebrobasilar blood flow velocity changes, changes in neurological deficit function and clinical efficacy of two groups of patients were compared. Results After treatment, basilar artery (BA), left vertebral artery (LVA) and right vertebral artery (RVA) in both groups were significantly higher than those before treatment (all P <0.05); and the observation group was significantly higher than the control group P <0.05). After treatment, the neurological deficits and daily living ability of both groups were better than those before treatment (all P <0.05); and the observation group was significantly better than the control group (all P <0.05). The total effective rate in the observation group was 97.06%, which was significantly higher than that in the control group (89.71%), the difference was statistically significant (P <0.05). Conclusion The combination of edaravone and Shuxuetong can improve the blood flow of vertebrobasilar artery in patients with cerebral infarction and improve the neurological deficit effectively and improve the curative effect of clinical treatment.